YD BioYDES
13F holders, Q2 2026 (June 30)13holders +5
5new positions
0sold out
1famous investor
$2.25avg. 13F price*
At the end of Q2 2026, 13 institutions reported holding YD Bio Ltd. (YDES) in their 13F filings, up 5 from Q1 2026. 5 opened new positions and 0 sold out. The largest holders were Garrett Wealth Advisory Group, LLC ($190K), Geode Capital Management, LLC ($141K) and Cypress Capital Management LLC (WY) ($76K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- YD Bio Ltd.
- CUSIP
- G98301107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $243K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 124,912 shares bought and 63 shares sold, net +124,849 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Garrett Wealth Advisory Group, LLC | 0.03% | New | 84,630 | $190K |
| Geode Capital Management, LLC | 0.00% | Add +4.1% | 62,714 | $141K |
| Cypress Capital Management LLC (WY) | 0.06% | Add +9.8% | 33,690 | $76K |
| Cerity Partners LLC | 0.00% | No change | 32,406 | $73K |
| Citadel Advisors | 0.00% | Add +54.8% | 30,106 | $68K |
| Jane Street Group, LLC | 0.00% | New | 21,423 | $48K |
| UBS Group AG | 0.00% | Add +6.5% | 12,384 | $28K |
| Wolverine Asset Management LLC | 0.00% | No change | 4,886 | $11K |
| SkyView Investment Advisors, LLC | 0.00% | New | 1,777 | $4K |
| Morgan Stanley | 0.00% | Reduce -28.3% | 160 | $360 |
| Wells Fargo & Company | 0.00% | New | 75 | $169 |
| FMR LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | New | 117 | $0 |
"% of holder's portfolio" is YDES's weight in each manager's 13F, not the share of YD Bio Ltd. the manager owns.